PDS Biotechnology Corp Deferred Tax Liabilities, Net, Noncurrent
PDS Biotechnology Corp (PDSB) had Deferred Tax Liabilities, Net, Noncurrent of $157.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-11-07
- 2019-09-30: Deferred Tax Liabilities, Net, Noncurrent $157.00K.
- 2019-06-30: Deferred Tax Liabilities, Net, Noncurrent $157.00K.
- 2019-03-31: Deferred Tax Liabilities, Net, Noncurrent $157.00K.
- 2018-12-31: Deferred Tax Liabilities, Net, Noncurrent $0.00.
| Period end | Deferred Tax Liabilities, Net, Noncurrent |
|---|---|
| 2019-09-30 | $157.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $157.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $157.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |